Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Leiris, Nicolas De"'
Autor:
Flaus, Anthime, Deddah, Tahya, Reilhac, Anthonin, Leiris, Nicolas De, Janier, Marc, Merida, Ines, Grenier, Thomas, McGinnity, Colm J., Hammers, Alexander, Lartizien, Carole, Costes, Nicolas
Publikováno v:
Frontiers in Medicine. 9
Introduction[18F]fluorodeoxyglucose ([18F]FDG) brain PET is used clinically to detect small areas of decreased uptake associated with epileptogenic lesions, e.g., Focal Cortical Dysplasias (FCD) but its performance is limited due to spatial resolutio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0003f3c58d5c650b71f896df99bf6d
https://doi.org/10.3389/fmed.2022.1042706
https://doi.org/10.3389/fmed.2022.1042706
Autor:
Montemagno C; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Dumas L; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France.; Advanced Accelator Applications, 01630 Saint-Genis-Pouilly, France., Cavaillès P; Natural Barriers and Infectiosity, Universite Grenoble Alpes, CNRS, CHU Grenoble Alpes, TIMC-IMAG, 38000 Grenoble, France., Ahmadi M; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Bacot S; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Debiossat M; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Soubies A; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Djaïleb L; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Leenhardt J; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Leiris N; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Dufies M; Biomedical Department, Centre Scientifique de Monaco, 980000 Monaco, Monaco., Pagès G; Biomedical Department, Centre Scientifique de Monaco, 980000 Monaco, Monaco.; Institute for Research on Cancer and Aging of Nice, Universite Cote d'Azur, CNRS UMR 7284, INSERM U1081, Centre Antoine Lacassagne, 061489 Nice, France., Hernot S; Laboratory of In Vivo Cellular and Molecular Imaging, ICMI-BEFY, Vrije Universiteit Brussel, Laarbeeklan 103, B-1090 Brussels, Belgium., Devoogdt N; Laboratory of In Vivo Cellular and Molecular Imaging, ICMI-BEFY, Vrije Universiteit Brussel, Laarbeeklan 103, B-1090 Brussels, Belgium., Perret P; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Riou L; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Fagret D; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Ghezzi C; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France., Broisat A; Laboratory of Bioclinical Radiopharmaceutics, Universite Grenoble Alpes, Inserm, CHU Grenoble Alpes, LRB, 38000 Grenoble, France. alexis.broisat@inserm.fr.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Jul 23; Vol. 11 (7). Date of Electronic Publication: 2019 Jul 23.